Fact CheckerSign in

NCT06458361Completed

Identification of Risk Factors and Construction of Prediction Model for Postoperative Intestinal Anastomotic Leakage in Ovarian Cancer

Source: ClinicalTrials.gov · Last updated 16 Jul 2026

Brief summary (registry, in English)

This study was a multicenter, retrospective cohort study. Although advancements in surgical techniques have mitigated the incidence of intestinal anastomotic fistula, complete avoidance remains elusive. Anastomotic leakage (AL) complications directly impinge on postoperative quality of life and pose life-threatening risks if inadequately managed. Given AL's adverse prognostic implications and the financial strain on patients' families, identifying its risk factors aids in perioperative risk assessment, enabling timely clinical decisions on interventions to enhance prognosis and curtail adverse outcomes and economic investments.

Status (registry)
Completed
Study type
Observational
Enrollment
401 (actual)
First submitted
8 Jun 2024
Start date
1 Jan 2018
Primary completion date
30 Jun 2025
Lead sponsor
Zhongda Hospital
NCT number
NCT06458361

What you commit to

  • Study type: Observational
  • Participants enrolled: 401
  • From 1 Jan 2018 to the primary completion date, 30 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous combination of malignant tumours of other organs

Other illness

  • Comorbidities with serious diseases related to other organs

Other

  • Patients undergoing secondary tumour cytoreduction

Who the study is looking for

  • Patients with postoperative pathological diagnosis of primary ovarian, fallopian tube or peritoneal cancer
  • Patients undergoing tumour cytoreductive surgery combined with colorectal resection and stage I intestinal anastomosis
  • No history of other malignant tumours
  • Complete case data

Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Zhongda Hospital
Coordinator of this site? Confirm its status
NanjingChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.